Cosmos Health Inc. is a diversified, vertically integrated global healthcare group specializing in pharmaceuticals, nutraceuticals, healthcare services, and digital assets. The company engages in the importation, exportation, distribution, and sale of pharmaceutical products, including over-the-counter drugs, branded and generic medicines, vitamins, minerals, dietary supplements, medical devices, and baby products. It manufactures and markets proprietary brands such as Sky Premium Life, NOOR Collagen, C-Sept, C-Scrub antimicrobial cleansers, and Mediterranation, with operations spanning Europe, the United States, the UK, UAE, and other regions. Cosmos Health Inc. operates manufacturing facilities like Cana Laboratories for contract production, distribution networks including CosmoFarm with robotic automation for pharmacy logistics, and telehealth initiatives. It conducts research and development through platforms like Cloudscreen AI for drug repurposing, focusing on nutraceutical formulas, nanotechnology, and compounds targeting obesity and other disorders. Additionally, the company manages a digital asset treasury featuring Bitcoin and Ethereum holdings to diversify its balance sheet. Serving wholesalers, pharmacies, clinics, retailers like Tesco and Superdrug, and healthcare providers, Cosmos Health Inc. supports a broad ecosystem in wellness and medical distribution. Founded in 2009 and headquartered in Thessaloniki, Greece, it plays a key role in bridging manufacturing, innovation, and global supply chains in the healthcare sector.